AI-generated analysis. Always verify with the original filing.
Oramed Pharmaceuticals Inc. entered into a Warrant Agreement on February 19, 2026. The agreement, dated February 17, 2026, is filed as Exhibit 10.1.
Event Type
Disclosure
Mandatory
Variant
8-K
Entry into a Material Definitive Agreement . On February 19, 2026, Oramed Pharmaceuticals Inc. (the “Company”) entered into a Warrant Agreement (the “Warrant Ag
Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 10.1 Warrant Agreement, dated as of February 17, 2026, by and among Oramed Pharmaceut
Material Agreement